Point State Capital LP Regeneron Pharmaceuticals, Inc. Transaction History

Point State Capital LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$543.48 - $670.97 $16.3 Million - $20.1 Million	-30,020 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $4.03 Million - $4.78 Million	7,020 Added 30.52%	30,020 $18.2 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $10.9 Million - $12.8 Million	23,000 New	23,000 $12.8 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $16 Million - $19.6 Million	-35,733 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $9.24 Million - $11.7 Million	19,313 Added 117.62%	35,733 $17.3 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $14.1 Million - $17.1 Million	-25,927 Reduced 61.23%	16,420 $9.19 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $16.2 Million - $21.1 Million	32,804 Added 343.75%	42,347 $26.4 Million
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $42 Million - $61.8 Million	-125,025 Reduced 92.91%	9,543 $4.66 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $33 Million - $45.3 Million	120,368 Added 847.66%	134,568 $50.5 Million
Q3 2019 Nov 14, 2019	BUY	$273.46 - $318.39 $3.88 Million - $4.52 Million	14,200 New	14,200 $3.94 Million
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $68.7 Million - $80.2 Million	-159,220 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	159,220	159,220 $78.2 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.